Non-transplant therapies for patients with hepatocellular carcinoma and Child-Pugh-Turcotte class B cirrhosis
Open Access
- 1 February 2017
- journal article
- review article
- Published by Elsevier BV in The Lancet Oncology
- Vol. 18 (2), e101-e112
- https://doi.org/10.1016/s1470-2045(16)30569-1
Abstract
No abstract availableThis publication has 74 references indexed in Scilit:
- Sorafenib in patients with Child-Pugh class A and B advanced hepatocellular carcinoma: a prospective feasibility analysisAnnals of Oncology, 2013
- EASL–EORTC Clinical Practice Guidelines: Management of hepatocellular carcinomaEuropean Journal of Cancer, 2012
- Local-Regional Treatment of Hepatocellular CarcinomaRadiology, 2012
- Field-practice study of sorafenib therapy for hepatocellular carcinoma: A prospective multicenter study in ItalyJournal of Hepatology, 2011
- Management of hepatocellular carcinoma: An updateJournal of Hepatology, 2011
- Asian Pacific Association for the Study of the Liver consensus recommendations on hepatocellular carcinomaHepatology International, 2010
- Prospective Randomized Study of Doxorubicin-Eluting-Bead Embolization in the Treatment of Hepatocellular Carcinoma: Results of the PRECISION V StudyCardioVascular and Interventional Radiology, 2009
- Sorafenib in Advanced Hepatocellular CarcinomaThe New England Journal of Medicine, 2008
- Changes in hepatic functional reserve after percutaneous tumor ablation for hepatocellular carcinoma: long-term follow up for 227 consecutive patients with a single lesionHepatology International, 2007
- Staging of Hepatocellular CarcinomaAnnals of Surgery, 2007